The No Taxpayer-Funded Settlement Slush Funds Act of 2026 prohibits the use of federal money to pay specific settlements involving high-ranking government officials and their close associates. It bars payments to the President, Vice President, their immediate families, cabinet members, senior executive staff, political appointees, and individuals connected to these roles, as well as any entity owned by the President or Vice President. Additionally, the bill restricts settlements related to claims about the January 6 Capitol attack, foreign election interference, or previously dismissed lawsuits, while requiring Treasury reports for large settlements and allowing the government to seek repayment if rules are broken.
The Waste Heat to Wattage Act of 2026 amends the definition of renewable energy under the Farm Security and Rural Investment Act of 2002 to include "waste energy recovery." Specifically, it adds waste energy recovery - defined as heat or pressure from industrial processes that would otherwise be wasted - to the list of eligible renewable energy sources. This change directly affects industrial facilities that capture waste heat or pressure to generate electricity through systems like waste heat to power. The bill updates existing law to recognize this technology as renewable energy, without creating new programs or funding.
Hemp Planting Predictability Act This bill extends by two years the implementation of changes to the regulation of hemp products, which reimpose certain federal controls over some hemp products. Specifically, Congress enacted the FY2026 agriculture appropriations act (P.L. 119-37) on November 12, 2025. Effective November 12, 2026, the act modifies the statutory definition of hemp products that are considered to be lawful. This bill extends the effective date to November 12, 2028. As background, the 2018 farm bill excluded hemp from the Controlled Substances Act definition of marijuana and defined hemp . As a result, hemp and hemp-derived products at or below the 0.3% delta-9 tetrahydrocannabinol (THC, the psychoactive component of marijuana) concentration threshold were no longer regulated as Schedule I controlled substances and registration with the Drug Enforcement Administration was no longer required to cultivate or handle hemp and hemp-derived products. However, hemp remained subject to Department of Agriculture and Food and Drug Administration regulation. The 2025 changes to the definition of hemp, include changing the limit to a total THC concentration of not more than 0.3% on a dry weight basis rather than only delta-9 THC, explicitly including industrial hemp, excluding seeds from a cannabis plant that exceed a certain THC concentration, and excluding various types of hemp-derived cannabinoid products. Cannabinoids refer to unique chemical compounds that are found in hemp and marijuana (e.g., THC) and are known to exhibit a range of psychological and physiological effects.
This bill extends by two years the implementation of changes to the regulation of hemp products, which reimpose certain federal controls over some hemp products. Specifically, Congress enacted the FY2026 agriculture appropriations act (P.L. 119-37) on November 12, 2025. Effective November 12, 2026, the act modifies the statutory definition of hemp products that are considered to be lawful. This bill extends the effective date to November 12, 2028. As background, the 2018 farm bill excluded hemp from the Controlled Substances Act definition of marijuana and defined hemp . As a result, hemp and hemp-derived products at or below the 0.3% delta-9 tetrahydrocannabinol (THC, the psychoactive component of marijuana) concentration threshold were no longer regulated as Schedule I controlled substances and registration with the Drug Enforcement Administration was no longer required to cultivate or handle hemp and hemp-derived products. However, hemp remained subject to Department of Agriculture and Food and Drug Administration regulation. The 2025 changes to the definition of hemp, include changing the limit to a total THC concentration of not more than 0.3% on a dry weight basis rather than only delta-9 THC, explicitly including industrial hemp, excluding seeds from a cannabis plant that exceed a certain THC concentration, and excluding various types of hemp-derived cannabinoid products. Cannabinoids refer to unique chemical compounds that are found in hemp and marijuana (e.g., THC) and are known to exhibit a range of psychological and physiological effects.
The ARCA Act of 2025 aims to reform the Department of Veterans Affairs' (VA) acquisition process, directly impacting how the VA procures services, supplies, and technology for veterans. It establishes an Assistant Secretary for Acquisition and an Office of Acquisition to consolidate all major acquisition, procurement, logistics, and supply chain functions under a single authority. The bill creates a Director of Cost Assessment and Program Evaluation to conduct independent cost estimates and evaluations, and mandates independent verification and validation for major acquisition programs. Additionally, it requires a standardized requirements development process for major programs and expands entry-level acquisition internship programs to strengthen the VA's acquisition workforce.
The VISN Reform Act of 2025 reorganizes the Veterans Health Administration’s 23 regional networks (VISNs) into eight geographically defined networks. It requires consolidating specific existing VISNs (e.g., combining VISNs 1, 2, and 4 into one network) and limits each VISN headquarters to 50 employees (no more than 10 contractors). The bill mandates a reorganization plan within 180 days of enactment, focusing on reducing duplicate functions, aligning services with veteran needs, and ensuring headquarters staff do not reduce access to care. This directly affects VA healthcare operations, including facility management, staffing at VISN headquarters, and coordination with state/local veteran services. The reform aims to streamline administration while maintaining accountability through annual reports to Congress and triennial network reviews.
This bill reauthorizes and strengthens the Civil Rights Cold Case Records Collection program. It establishes that all federal, state, and local government records related to historical civil rights cases must carry a presumption of immediate public disclosure, with full access intended for public understanding. Key provisions include allowing the Review Board to reimburse state/local governments for digitizing or copying records to add to the national collection, removing an exception that previously blocked state records from being included, and extending the Review Board's term from 7 to 11 years. The bill directly affects government agencies holding these records and the public seeking historical transparency about civil rights cases.
This bill protects funding and staffing at the Department of Veterans Affairs (VA). It prevents the government from holding back or redirecting VA funds without new law, and requires the VA to notify Congress if funding shortfalls approach. The bill exempts the VA from hiring freezes through 2029, mandates reinstating veterans fired between 2025 and the bill’s enactment, and requires special legal authorization for layoffs (including probationary employees). The VA must also submit annual compliance reports to Congress.
Dental Care for Veterans Act This bill expands eligibility for veterans for dental care provided by the Department of Veterans Affairs (VA). Specifically, the bill makes all veterans who are enrolled in the VA health care system eligible for VA-provided dental services. Currently, only veterans who have a service-connected dental issue or meet other narrow criteria are eligible for certain dental services. The bill phases in eligibility over four years based upon existing eligibility, degree of service-connected disability or other disability, prisoner of war status, award of a Purple Heart, financial need, or VA health care eligibility.
The Jewish American Security Act aims to combat antisemitism by strengthening protections for Jewish students, securing Jewish communities, and increasing transparency regarding online hate speech. To support Jewish students, the bill requires schools receiving federal funds to designate coordinators for civil rights complaints, issue annual reminders about anti-discrimination policies, and publish detailed data on bias-related incidents. For community safety, the legislation increases funding for security grants for religious institutions and mandates joint annual threat assessments from federal agencies to track domestic and transnational antisemitic violence. Additionally, the act requires major online platforms to submit regular transparency reports detailing how they detect, remove, and moderate antisemitic content on their sites.
The IMPACT to Save Moms Act directs the Centers for Medicare & Medicaid Services to run a five-year demonstration project from 2027 to 2031, allowing states to test new payment models for maternity care under Medicaid and state child health plans. This initiative aims to improve health outcomes for pregnant and postpartum individuals, with a specific focus on reducing disparities among groups that experience higher rates of maternal mortality and severe complications. To achieve these goals, the project requires states to consider alternative payment structures that account for pregnancy risk levels, include diverse care teams with training on bias, and address social factors affecting health. The bill also mandates that the federal government evaluate the project's impact on health outcomes and spending, and submit a final report to Congress with recommendations on whether to expand the program nationwide.
HR 8901, the Securing Innovation and Research from Adversaries Act, prohibits federally funded researchers and institutions from collaborating with entities on specific U.S. government restricted lists, such as those related to national security risks or forced labor. The bill defines research collaboration broadly to include joint projects, data sharing, co-authorship, and personnel exchanges, and it requires agencies to issue guidance for standardized compliance. While the law generally bans these partnerships, it allows federal agency heads to grant case-by-case waivers if the collaboration is essential for national security or critical scientific purposes, provided they report the decision and justification to Congress within 30 days.
